Agios Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
AGIO
CUSIP
00847X104
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 6 38.0 k $1.26 M
2025 Q1 231 60.0 M $1.76 B
2024 Q4 238 59.8 M $1.97 B
2024 Q3 228 59.7 M $2.65 B
2024 Q2 224 60.7 M $2.62 B
2024 Q1 209 67.1 M $1.96 B
2023 Q4 187 63.8 M $1.42 B
2023 Q3 162 59.4 M $1.47 B
2023 Q2 167 59.4 M $1.68 B
2023 Q1 179 59.2 M $1.36 B
2022 Q4 178 62.7 M $1.76 B
2022 Q3 189 58.4 M $1.65 B
2022 Q2 170 59.2 M $1.31 B
2022 Q1 182 60.2 M $1.75 B
2021 Q4 181 59.4 M $1.95 B
2021 Q3 178 60.9 M $2.81 B
2021 Q2 203 65.9 M $3.63 B
2021 Q1 193 65.3 M $3.37 B
2020 Q4 231 65.6 M $2.84 B
2020 Q3 230 65.9 M $2.30 B
2020 Q2 238 67.9 M $3.63 B
2020 Q1 226 69.6 M $2.48 B
2019 Q4 225 70.0 M $3.34 B
2019 Q3 212 63.1 M $2.05 B
2019 Q2 214 61.3 M $3.06 B
2019 Q1 224 60.1 M $4.06 B
2018 Q4 218 58.6 M $2.70 B
2018 Q3 231 57.0 M $4.39 B
2018 Q2 238 54.9 M $4.63 B
2018 Q1 216 55.7 M $4.55 B
2017 Q4 193 47.0 M $2.69 B
2017 Q3 186 46.1 M $3.07 B
2017 Q2 183 46.2 M $2.37 B
2017 Q1 170 41.1 M $2.40 B
2016 Q4 176 39.1 M $1.63 B
2016 Q3 177 37.9 M $2.00 B
2016 Q2 166 34.1 M $1.43 B
2016 Q1 168 33.8 M $1.37 B
2015 Q4 160 33.2 M $2.15 B
2015 Q3 160 31.5 M $2.22 B
2015 Q2 169 30.1 M $3.35 B
2015 Q1 158 28.0 M $2.64 B
2014 Q4 155 27.7 M $3.10 B
2014 Q3 125 24.5 M $1.50 B
2014 Q2 105 24.9 M $1.14 B
2014 Q1 76 20.5 M $804 M